KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Gross Margin (2017 - 2025)

Twist Bioscience (TWST) has disclosed Gross Margin for 9 consecutive years, with 52.05% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 376.0% to 52.05% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 51.62% through Dec 2025, up 703.0% year-over-year, with the annual reading at 50.72% for FY2025, 811.0% up from the prior year.
  • Gross Margin for Q4 2025 was 52.05% at Twist Bioscience, up from 51.35% in the prior quarter.
  • The five-year high for Gross Margin was 53.4% in Q2 2025, with the low at 30.76% in Q1 2023.
  • Average Gross Margin over 5 years is 42.78%, with a median of 42.15% recorded in 2024.
  • The sharpest move saw Gross Margin surged 1789bps in 2021, then crashed -1045bps in 2023.
  • Over 5 years, Gross Margin stood at 35.61% in 2021, then increased by 28bps to 45.72% in 2022, then decreased by -11bps to 40.51% in 2023, then rose by 19bps to 48.29% in 2024, then rose by 8bps to 52.05% in 2025.
  • According to Business Quant data, Gross Margin over the past three periods came in at 52.05%, 51.35%, and 53.4% for Q4 2025, Q3 2025, and Q2 2025 respectively.